KEN vs TEVA vs VTRS vs AMTD vs AMRX

For growth investors, Kenon Holdings Ltd.

(KEN) is the stronger pick with 8. 6% revenue growth year-over-year, versus -55. 9% for AMTD IDEA Group (AMTD). AMTD IDEA Group (AMTD) offers the better valuation at 0. 3x trailing P/E, making it the more compelling value choice. Analysts rate Teva Pharmaceutical Industries Limited (TEVA) a "Buy" — based on 46 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, AMTD IDEA Group (AMTD) is the cheapest at 0.

3x versus Amneal Pharmaceuticals, Inc. at 62. 4x. On forward P/E, Viatris Inc. is actually cheaper at 7. 1x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Teva Pharmaceutical Industries Limited (TEVA) delivered a total return of +246.

2%, compared to -97. 4% for AMTD IDEA Group (AMTD). Over 10 years, the gap is even starker: KEN returned +1257% versus AMTD's -91. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), AMTD IDEA Group (AMTD) is the lower-risk stock at 0.

06β versus Amneal Pharmaceuticals, Inc. 's 1. 17β — meaning AMRX is approximately 1758% more volatile than AMTD relative to the S&P 500. On balance sheet safety, Amneal Pharmaceuticals, Inc. (AMRX) carries a lower debt/equity ratio of 13% versus 2% for Teva Pharmaceutical Industries Limited — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Kenon Holdings Ltd.

(KEN) is pulling ahead at 8. 6% versus -55. 9% for AMTD IDEA Group (AMTD). On earnings-per-share growth, the picture is similar: Kenon Holdings Ltd. grew EPS 356. 6% year-over-year, compared to -466. 0% for Viatris Inc.. Over a 3-year CAGR, KEN leads at 15. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

AMTD IDEA Group (AMTD) is the more profitable company, earning 94.

4% net margin versus -24. 6% for Viatris Inc. — meaning it keeps 94. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMTD leads at 48. 2% versus -18. 6% for VTRS. At the gross margin level — before operating expenses — TEVA leads at 51. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Viatris Inc.

(VTRS) trades at 7. 1x forward P/E versus 14. 5x for Teva Pharmaceutical Industries Limited — 7. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AMRX: 23. 9% to $17. 00.

In this comparison, AMTD (36.

7% yield), KEN (4. 4% yield), VTRS (2. 8% yield) pay a dividend. TEVA, AMRX do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Kenon Holdings Ltd.

(KEN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 90), 4. 4% yield, +1257% 10Y return). Both have compounded well over 10 years (KEN: +1257%, AMRX: -54. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (KEN (Utilities) and TEVA (Healthcare) and VTRS (Healthcare) and AMTD (Financial Services) and AMRX (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: KEN is a small-cap deep-value stock; TEVA is a mid-cap quality compounder stock; VTRS is a mid-cap quality compounder stock; AMTD is a small-cap deep-value stock; AMRX is a small-cap quality compounder stock. KEN, VTRS, AMTD pay a dividend while TEVA, AMRX do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.